Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.
Adenovirus Infections, Human
B-Lymphocytes
Bone Marrow Failure Disorders
Child
Fatal Outcome
Female
Hematopoietic Stem Cell Transplantation
Heterozygote
Humans
Immunoglobulins, Intravenous
/ therapeutic use
Immunologic Factors
/ therapeutic use
Immunologic Memory
Lymphopenia
Mutation
Recurrence
Severe Combined Immunodeficiency
/ genetics
T-Lymphocytes
Virus Diseases
rac GTP-Binding Proteins
/ genetics
RAC2 GTP-Binding Protein
Dominant activating RAC2 mutation
Infantile-onset humoral immunodeficiency
Viral infections
Journal
Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
29
01
2019
revised:
30
04
2019
accepted:
05
05
2019
pubmed:
10
5
2019
medline:
21
4
2020
entrez:
10
5
2019
Statut:
ppublish
Résumé
Here we describe a 10-year-old girl with combined immunodeficiency presenting as recurring chest infections, lung disease and herpetic skin infections. The patient experienced two hematopoietic stem cell transplantations and despite full chimerism, she developed bone marrow aplasia due to adenovirus infection and died at post-transplant day 86. Immunologic investigation revealed low numbers of TRECs/KRECs, a severe reduction of memory B cells, absence of isohemagglutinins, and low IgG levels. Whole exome sequencing (WES) identified a novel heterozygous mutation in RAC2(c.275A > C, p.N92 T). Flow cytometric investigation of neutrophil migration demonstrated an absence of chemotaxis to fMLP. Cell lines transfected with RAC2 [N92 T] displayed characteristics of active GTP-bound RAC2 including enhanced NADPH oxidase-derived superoxide production both at rest and in response to PMA. Our findings broaden the clinical picture of RAC2 dysfunction, showing that some individuals can present with a combined immunodeficiency later in childhood rather than a congenital neutrophil disease.
Identifiants
pubmed: 31071452
pii: S1521-6616(19)30041-5
doi: 10.1016/j.clim.2019.05.003
pii:
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
Immunologic Factors
0
rac GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-5Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.